181 related articles for article (PubMed ID: 30924071)
1. Health state utilities associated with attributes of migraine preventive treatments based on patient and general population preferences.
Matza LS; Deger KA; Vo P; Maniyar F; Goadsby PJ
Qual Life Res; 2019 Sep; 28(9):2359-2372. PubMed ID: 30924071
[TBL] [Abstract][Full Text] [Related]
2. Patient Preferences for Preventive Migraine Treatments: A Discrete-Choice Experiment.
Mansfield C; Gebben DJ; Sutphin J; Tepper SJ; Schwedt TJ; Sapra S; Shah N
Headache; 2019 May; 59(5):715-726. PubMed ID: 30861110
[TBL] [Abstract][Full Text] [Related]
3. Health state utilities associated with attributes of treatments for hepatitis C.
Matza LS; Sapra SJ; Dillon JF; Kalsekar A; Davies EW; Devine MK; Jordan JB; Landrian AS; Feeny DH
Eur J Health Econ; 2015 Dec; 16(9):1005-18. PubMed ID: 25481796
[TBL] [Abstract][Full Text] [Related]
4. Patient preferences and health state utilities associated with the treatment process of antiretroviral therapy for people living with HIV.
Matza LS; Howell TA; Chounta V; van de Velde N
Qual Life Res; 2023 Feb; 32(2):531-541. PubMed ID: 36512302
[TBL] [Abstract][Full Text] [Related]
5. Health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes.
Matza LS; Boye KS; Stewart KD; Davies EW; Paczkowski R
BMC Health Serv Res; 2017 Nov; 17(1):774. PubMed ID: 29178918
[TBL] [Abstract][Full Text] [Related]
6. Health state utilities associated with treatment process for oral and injectable GLP-1 receptor agonists for type 2 diabetes.
Matza LS; Cutts KN; Stewart KD; Norrbacka K; García-Pérez LE; Boye KS
Qual Life Res; 2021 Jul; 30(7):2033-2043. PubMed ID: 33886044
[TBL] [Abstract][Full Text] [Related]
7. Acute and chronic impact of cardiovascular events on health state utilities.
Matza LS; Stewart KD; Gandra SR; Delio PR; Fenster BE; Davies EW; Jordan JB; Lothgren M; Feeny DH
BMC Health Serv Res; 2015 Apr; 15():173. PubMed ID: 25896804
[TBL] [Abstract][Full Text] [Related]
8. Health state utilities associated with treatment for transfusion-dependent β-thalassemia.
Matza LS; Paramore LC; Stewart KD; Karn H; Jobanputra M; Dietz AC
Eur J Health Econ; 2020 Apr; 21(3):397-407. PubMed ID: 31828456
[TBL] [Abstract][Full Text] [Related]
9. Estimating health state utilities associated with a rare disease: familial chylomicronemia syndrome (FCS).
Matza LS; Phillips GA; Howell TA; Ciffone N; Ahmad Z
J Med Econ; 2020 Sep; 23(9):978-984. PubMed ID: 32479143
[No Abstract] [Full Text] [Related]
10. Patient preferences in Italy: health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes.
Matza LS; Boye KS; Jordan JB; Norrbacka K; Gentilella R; Tiebout AR; Browne C; Orsini Federici M; Biricolti G; Stewart KD
Patient Prefer Adherence; 2018; 12():971-979. PubMed ID: 29922043
[TBL] [Abstract][Full Text] [Related]
11. Health State Utilities Associated with Glucose Monitoring Devices.
Matza LS; Stewart KD; Davies EW; Hellmund R; Polonsky WH; Kerr D
Value Health; 2017 Mar; 20(3):507-511. PubMed ID: 28292497
[TBL] [Abstract][Full Text] [Related]
12. Health State Utilities for Adverse Events Associated with Chimeric Antigen Receptor T-Cell Therapy in Large B-Cell Lymphoma.
Howell TA; Matza LS; Jun MP; Garcia J; Powers A; Maloney DG
Pharmacoecon Open; 2022 May; 6(3):367-376. PubMed ID: 35129829
[TBL] [Abstract][Full Text] [Related]
13. Risks associated with antiretroviral treatment for human immunodeficiency virus (HIV): qualitative analysis of social media data and health state utility valuation.
Matza LS; Chung KC; Kim KJ; Paulus TM; Davies EW; Stewart KD; McComsey GA; Fordyce MW
Qual Life Res; 2017 Jul; 26(7):1785-1798. PubMed ID: 28341926
[TBL] [Abstract][Full Text] [Related]
14. The impact of different scenarios for intermittent bladder catheterization on health state utilities: results from an internet-based time trade-off survey.
Averbeck MA; Krassioukov A; Thiruchelvam N; Madersbacher H; Bøgelund M; Igawa Y
J Med Econ; 2018 Oct; 21(10):945-952. PubMed ID: 29882712
[TBL] [Abstract][Full Text] [Related]
15. A stated preference survey to explore patient preferences for novel preventive migraine treatments.
Hubig LT; Smith T; Chua GN; Lloyd AJ; Powell L; Johnston K; Harris L; L'Italien G; Coric V; Lo SH
Headache; 2022 Oct; 62(9):1187-1197. PubMed ID: 36047857
[TBL] [Abstract][Full Text] [Related]
16. Health state utilities associated with hyperphagia: Data for use in cost-utility models.
Howell TA; Matza LS; Mallya UG; Goldstone AP; Butsch WS; Lazarus E
Obes Sci Pract; 2023 Aug; 9(4):376-382. PubMed ID: 37546284
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
18. Developing a preference-based utility scoring algorithm for the Psoriasis Area Severity Index (PASI).
Matza LS; Brazier JE; Stewart KD; Pinto L; Bender RH; Kircik L; Jordan J; Kim KJ; Mutebi A; Viswanathan HN; Menter A
J Med Econ; 2019 Sep; 22(9):936-944. PubMed ID: 31161828
[No Abstract] [Full Text] [Related]
19. Health state utilities for skeletal-related events secondary to bone metastases.
Matza LS; Chung K; Van Brunt K; Brazier JE; Braun A; Currie B; Palsgrove A; Davies E; Body JJ
Eur J Health Econ; 2014 Jan; 15(1):7-18. PubMed ID: 23355121
[TBL] [Abstract][Full Text] [Related]
20. Utilities and disutilities for attributes of injectable treatments for type 2 diabetes.
Boye KS; Matza LS; Walter KN; Van Brunt K; Palsgrove AC; Tynan A
Eur J Health Econ; 2011 Jun; 12(3):219-30. PubMed ID: 20224930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
